Premium
Hydroxychloroquine and Azithromycin to Treat Patients With COVID‐19: Both Friends and Foes?
Author(s) -
Mégarbane Bruno,
Scherrmann JeanMichel
Publication year - 2020
Publication title -
the journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.92
H-Index - 116
eISSN - 1552-4604
pISSN - 0091-2700
DOI - 10.1002/jcph.1646
Subject(s) - hydroxychloroquine , azithromycin , medicine , clinical trial , covid-19 , hazard ratio , pandemic , disease , confidence interval , infectious disease (medical specialty) , microbiology and biotechnology , biology , antibiotics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom